MEDI8897
D5290C00003
Phase 2 small_molecule completed
Quick answer
MEDI8897 for Respiratory Syncytial Virus Infections is a Phase 2 program (small_molecule) at MedImmune with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MedImmune
- Indication
- Respiratory Syncytial Virus Infections
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed